Summary
Join IQVIA and Goodwin for a joint workshop focused on how biotechs can raise capital and deliver value in a changing world. Get perspectives on the short and long-term implications from experienced investors and biotech CEOs as well as best practice and practical tips from IQVIA’s clinical trial and Goodwin’s legal experts.
This event is for biotech CEOs, CFOs and C-suite contacts looking to raise funds and scale their business.
We are inviting a select group to this event, so please do RSVP as soon as possible, and if your plans change, please let us know.
Agenda
14:30 – 15:00 PM | Registration
15:00 – 15:15 PM | Session 1: The new world order and Biotech – what does it mean for fund-raising?
15:15 – 15:30 PM | Session 2: Current financing trends
15:30 – 15:45 PM | Session 3: Smarter clinical trial designs to accelerate the path to market
15:45 – 16:00 PM | Break
16:00 – 16:15 PM | Session 4: Legal and regulatory hurdles for clinical trials
16:15 – 17:00 PM | Session 5: Panel – How to build value as a Biotech?
17:00 – 18:00 PM | Networking Reception
Speakers
Michael Pehl
CEO,
Adcendo
Kevin Pojasek, PhD
President and CEO,
Enara Bio
Amit Shah MD
Principal,
SR One
Duncan Young
Executive Director, Oncology R&D Business Development,
AstraZeneca
Chris Ball
Client Partner,
IQVIA Biotech
Matt Simmons
Senior Director, Oncology Strategy,
IQVIA Biotech
- /en/people/m/mcgrath-sophie
Sophie C. McGrath
Partner